Strain NP 315 of Escherichia coli possesses a thermolabile fructose-1, 6-diphosphate (FDP) aldolase; its growth on carbohydrate substrates is inhibited probably as a consequence of the accumulation of high intracellular levels of FDP. Studies of one class of phenotypic revertants of strain NP 315 which have regained their ability to grow on C. substrates at 40 C showed that in these strains the buildup of the inhibitory FDP pool is prevented by additional mutations in enzymes catalyzing the conversion of the substrate offered in the medium to FDP. For example, mutations affecting 6-phosphogluconate dehydrogenase activity (gnd-) may be selected in great number without any mutagenesis and enrichment simply by isolating revertants of strain NP 315 able to grow on gluconate at 40 C. Similarly, an additional mutation in phosphoglucose isomerase (pgi-) restores the ability of these fda-gnd-strains to grow on glucose at 40 C. Glucose metabolism of these fda-gnd-pgi-strains was investigated. The enzymes of the Entner-Doudoroff pathway are induced to an appreciable extent upon growth of these mutants on glucose medium; further evidence for glucose degradation via this route (which normally is induced only in the presence of gluconate) was provided by following the fate of the Cl label of radioactive glucose in L-alanine. Predominant labeling of the carboxyl-carbon of L-alanine was observed, inciating a major contribution of the Entner-Doudoroff path to pyruvate formation from glucose. Chromatographic analysis of the intermediates of glucose metabolism showed further that glucose apparently is at least partly metabolized via a bypass consisting of the accumulation of extracellular gluconic acid which arises by dephosphorylation of 6-phosphogluconolactone and possibly of 6-phosphogluconate. This extracellular gluconate is then taken up and metabolized in the normal manner via the Entner-Doudoroff enzymes.
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The inhibitory effects of high sugar phosphate concentrations under conditions of any iinbalance in carbohydrate catabolism is well known (1) and is usually ascribed to a general toxicity of these components. Thus, growth of a mutant of Escherichia coli with a defective fructose-1, 6-diphosphate (FDP) aldolase (EC 4.1.2.13) is severely inhibited under conditions where high intracellular concentrations of FDP accumulate (1, 2) .
In an attempt to more closely characterize this growth inhibition, we have isolated revertants of the original temperature-sensitive FDP aldolase strain. One class of revertants could be identified as strains possessing mutations in enzymes leading from the C6 or C5 substrate 26E of the medium to FDP, thereby preventing accumulation of FDP. For example, growth inhibition on gluconate as carbon source is reversed by mutations (gnd-) affecting activity of gluconate-6-phosphate dehydrogenase (EC 1.1.1.44); similarly, glucose-supported growth was somewhat restored by mutations in gnd and phosphoglucose isomerase (EC 5.3.1.9) (pgi-). One of these apparent fda-gnd-pgi-mutants was used in the investigation of the path of glucose degradation because carbon flow through glycolysis and the hexosemonophosphate shunt should be prevented by the mutational blocks and the Entner-Doudoroff-path (5) (Fig. 1) should be repressed upon growth on glucose (10) . The results show that in these mutants the 
MATERIALS AND METHODS
The following strains were used: K-10, a prototrophic Hfr strain (rel-); strain NP 315 (fda-), a derivative of strain K-10 with a temperature-sensitive fructose-1,6-diphosphate aldolase (1); strain NP 3151 (fda-gnd-) is a spontaneous revertant of strain NP 315 scored for growth at 40 C on gluconate minimal plates. Strain NP 31515 (fda-gnd-pgi-) is a derivative of strain NP 3151; it was selected for growth at 40 C on glucose minimal medium plates.
The minimal medium used was a modified salt solution P of Fraenkel and Neidhardt (9) . Only one-half of the original phosphate concentration was employed, and it was supplemented with 0.2% (NH4)2SO4 and 0.4% of the indicated carbon source.
Plates contained 1.5% agar (Serva). Cultures were grown in gyratory water bath shakers; the bacterial growth was measured by following the optical density (OD) increase at 420 or 405 nm in a Zei,B PMQ II or an Eppendorf photometer.
Preparation of cell-free extracts and enzyme assays. For preparation of cell-free extracts, the cultures were grown to an OD420 of about 1.5 and harvested by centrifugation. The sedimented cells were washed once with the respective extraction buffer and subsequently broken by sonic treatment with a Branson sonic oscillator for three 1-min periods at setting no. 3 . The extracts were cleared by centrifugation for 20 min at 20,000 x g, and their protein concentration was determined quantitatively by the method of Lowry et al. (18) with bovine serum albumin as standard protein. The activities of phosphoglucose isomerase, glucose-6-phosphate dehydrogenase, gluconate-6-phosphate dehydrogenase, and gluconokinase were assayed in the reaction mixtures by the method of Fraenkel and Levisohn (10) ; the activities of 6-phosphogluconate dehydrase and 2-keto-3-deoxy-6-phosphogluconate aldolase were determined by employing the procedure of Kovachevich and Wood (16) as modified by Fradkin and Fraenkel (6) .
Analysis of sugar phosphates in the soluble pool and in the medium. The amount of sugar phosphates accumulated in the cellular pool and excreted into the medium was determined as described by Fraenkel (8 (11) . Quantitative evaluation of the radioactivity was done by cutting out or scraping off the respective area from the paper or plates and by counting in a toluene-0.5% diphenyloxazole scintillation mixture using a BF 5001 liquid scintillation spectrometer.
RESULTS AND DISCUSSION Growth studies. It has been shown previously that blocking carbon flow through glycolysis by a mutational alteration of FDP aldolase ( Fig. 1) Isolation of revertants. To gain more information about the site of growth inhibition by FDP, revertants of strain NP 315 (fda-) were isolated. At first, strains were selected which regained the ability to grow on gluconate minimal medium plates at 40 C. Spontaneous revertants to temperature-resistant growth on gluconate arose quite frequently. About 50 colonies per 108 cells plated appeared at 40 C. Fifty-six of these 40 C revertants were analyzed for the enzymes of gluconate metabolism and for inhibition of gluconate-6-phosphate dehydrogenase by FDP (3). Fifty-four of them turned out to possess a drastically reduced activity of gluconate-6-phosphate dehydrogenase (Table  1) . No change of the pattern of inhibition of gluconate-6-phosphate dehydrogenase by FDP could be found in the two residual strains. These apparent gnd-strains were used to select spontaneous revertants able to grow at 40 C on glucose minimal medium plates. A high temperature dependency of appearance of phenotypic glucose-positive revertants could be observed. At 35, 38, and 40 C about 8,000, 600, and 340 temperature-resistant colonies appeared per 3 x 108 cells plated, respectively.
Most of the low-temperature revertants showed improved FDP aldolase activities, whereas enzymatic analysis of a total of nine 40 C revertants revealed that, in addition to the fda and gnd mutations, seven of them showed a drastically reduced activity of phosphoglucose isomerase (Table 1) . Growth on fructose of (10) . The wild strain K-10 almost exclusively degrades glucose via glycolysis and the hexosemonophosphate route ( a Cells were grown in minimal medium with 0.4% carbon source; in the case of of the 40 C values the cultures were exposed to the high temperature for 60 min.
b Numbers in parentheses represent nanomoles of FDP leaked into the medium from an amount of cells equivalent to 1 mg of cellular protein. (17) . Figure 3 shows the results for strain NP 3151. At 30 C (Fig. 3A) levels of glucose-6-phosphate, 6-phosphogluconate, gluconolactone, and gluconate are small, but detectable. At 40 C (Fig. 3B ) a preferential accumulation of gluconate takes place. Figure 4A shows the results of the same experiment done with strain NP 31515 at 40 C.
Again, an accumulation of gluconate and also of glucose-6-phosphate and 6-phosphogluconate can be observed. No gluconolactone could be detected on the thin-layer plates in this experiment. 30 C cells of strain NP 31515 (not shown) essentially yield the same result. Figure 4B more directly demonstrates the intermediate role of gluconic acid in glucose metabolism by strain NP 31515. In this experiment, glycerol-grown cells were transferred to [1-4C] Dephosphorylation of 6-phosphogluconolactone would lead to increased levels of 6- gluconolactone which has been shown to be responsible for conferrring to lactonase-deficient cells the "maltose-blue" phenotype (17) . Strain NP 31515 was checked for this property and showed the maltose-blue characteristic on maltose-glycerol plates (17) both at 30 and 40 C. The preferential dephosphorylation of 6-phosphogluconolactone which is indicated by the maltose-blue phenotype should also be correlated with a decreased concentration of 6- phosphogluconate in the cellular pool. Indeed, strain NP 31515 accumulates less 6-phosphogluconate than glucose-6-phosphate in the soluble pool, which could (amongst other possible explanations) be interpreted as a preferential dephosphorylation of 6-phosphogluconolactone uCi/, umol) and 0.02 ml of glucose (2.6 mg/ml) and incubated at 40 C. Samples (0.02 ml) were taken, mixed with 0.02 ml of acetone, and chromatographed (17) . No gluconolactone could be detected on thin-layer plates. Symbols: 0, glucose; *, gluconate; A, glucose-6-phosphate; 0, 6-phosphogluconate. B, The experiment was done as described under A except that chloramphenicol was given together with the labeled glucose to cells of strain NP 31515 in a final concentration of 100 ,g/ml.
Samples (0.04 ml) were taken, the cells were removed from it by centrifugation, and 0.02 ml of the supernatant fluid were spotted directly onto the chromatograms. Symbols: 0, glucose; 0, gluconate; 0, 6-phosphoglaconate. No gluconolactone could be detected on cellulose thin-layer plates.
( Table 6 ). The high level of 6-phosphogluconate in the medium which could also be detected as metabolite in the experiments illustrated by Fig. 3 and 4 , however, provides additional evidence for 6-phosphogluconolactone excretion without any preceding dephosphorylation.
Several possible explanations could account for the observation that the fda-gnd-pgistrain metabolizes glucose via an apparently similar route as 6-phosphogluconolactonasedeficient strains (17) . (i) Either some metabolite which accumulates in these mutants could inhibit the activity of the lactonase (ii) Strain NP 31515 (fda-gnd-pgi-) also could carry a lesion in the pgl structural gene; this possibility, however, seems improbable because the gluconate and glucose positive revertants arose spontaneously with a frequency incompatible with the assumption of a double mutation; or (iii) the gnd mutation causes all metabolites prior to the lesion to accumulate, and the phosphatase involved in dephosphorylation preferentially acts on 6-phosphogluconolactone.
It still needs to be discussed why the pgignd-strains of E. coli isolated by Kupor and Fraenkel (17) by selection for inability to form colonies on glucose plates (17) do not exhibit the same pattern of glucose metabolism described for our fda-gnd-pgi-mutants (which were selected for ability for glucose supported growth). At the moment, no definite answer is possible. In vivo leakiness of the mutational blocks of our strains which could facilitate induction of the Entner-Doudoroff enzymes by the extracellular gluconate might be responsible for the different behaviour. The assumption of physiological leakiness is supported by the experiment of Fig. 4B . Conversion of glucose to gluconate in the absence of a functioning Entner-Doudoroff path may only be explained if some phosphoenolpyruvate necessary for glucose uptake may be formed either via glycolysis or the hexosemonophosphate route.
